Elevance Health Inc. Stock News

Elevance Health (ELV) concluded the recent trading session at $483.12, signifying a +0.76% move from its prior day's close.

The Cigna-Humana merger will provide the combined body with increased negotiation power with healthcare providers, pharmaceutical companies and other stakeholders.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

The competitive benefits of being a BCBSA licensee has helped ELV grow its member base faster than UnitedHealth, especially on the higher margin commercial side. I pinpoint Elevance's strategy and wha

Elevance Health (ELV) possesses solid growth attributes, which could help it handily outperform the market.

Investors interested in stocks from the Medical Services sector have probably already heard of Elevance Health (ELV) and Apollo Medical Holdings, Inc. (AMEH). But which of these two stocks presents in

Investors looking for stocks in the Medical Services sector might want to consider either Elevance Health (ELV) or HealthEquity (HQY). But which of these two stocks is more attractive to value investo

With ELV's underlying markets growing at around 6-7% and the normalized FCF yield sitting at 6.8% at the moment, ELV should be able to deliver low double-digit returns. The medical membership structur

Elevance Health (ELV) could produce exceptional returns because of its solid growth attributes.

Elevance Health: Buy This Compounder For Growing Dividends

Elevance Health: A High Conviction Defensive Blue Chip Buy

Elevance Health's (ELV) Q3 results gain on growing medical customer base and strong pharmacy product revenues. Adjusted net income is currently projected to be more than $33.00 per share for 2023.

Elevance Health (ELV) came out with quarterly earnings of $8.99 per share, beating the Zacks Consensus Estimate of $8.45 per share. This compares to earnings of $7.53 per share a year ago.

Elevance Health reported a better-than-expected third-quarter profit on Wednesday, helped by lower-than-expected medical costs for the health insurance provider.

Elevance Health (ELV) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.